Report overview
HAI is a term used to describe all infections that do not stem from the patient?s original diagnosis on admission.
HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infection Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infection Control. This report contains market size and forecasts of Hospital-Acquired Infection Control in global, including the following market information:
Global Hospital-Acquired Infection Control Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Hospital-Acquired Infection Control market was valued at US$ 5867.2 million in 2022 and is projected to reach US$ 7101.9 million by 2029, at a CAGR of 2.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Catheter-associated Urinary Tract Infections (CAUTIs) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hospital-Acquired Infection Control include GSK, Merck, Pfizer, 3M, Abbott, BD, Cepheid and Getinge Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital-Acquired Infection Control companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-Acquired Infection Control Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Hospital-Acquired Infection Control Market Segment Percentages, by Type, 2022 (%)
Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections
Global Hospital-Acquired Infection Control Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Hospital-Acquired Infection Control Market Segment Percentages, by Application, 2022 (%)
Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)
Global Hospital-Acquired Infection Control Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Hospital-Acquired Infection Control Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital-Acquired Infection Control revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital-Acquired Infection Control revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital-Acquired Infection Control, market overview.
Chapter 2: Global Hospital-Acquired Infection Control market size in revenue.
Chapter 3: Detailed analysis of Hospital-Acquired Infection Control company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital-Acquired Infection Control in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
